当前位置:
X-MOL 学术
›
Signal Transduct. Target Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Combination therapy for HCC: from CRISPR screening to the design of clinical therapies.
Signal Transduction and Targeted Therapy ( IF 39.3 ) Pub Date : 2021-10-04 , DOI: 10.1038/s41392-021-00775-1 Yunguang Wang 1, 2 , Ling Kui 3, 4 , Guangchuan Wang 2
中文翻译:
HCC 的联合治疗:从 CRISPR 筛选到临床治疗的设计。
更新日期:2021-10-04
Signal Transduction and Targeted Therapy ( IF 39.3 ) Pub Date : 2021-10-04 , DOI: 10.1038/s41392-021-00775-1 Yunguang Wang 1, 2 , Ling Kui 3, 4 , Guangchuan Wang 2
Affiliation
中文翻译:
HCC 的联合治疗:从 CRISPR 筛选到临床治疗的设计。